siRNA targeting KRAS
US7507811B2 · kind B2 · utility
90Cited by
3References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 2006 |
| Grant date | Mar 24, 2009 |
| Priority date | — |
| Expiry date | Jan 16, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/11
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.